The pediatrician's role in the diagnosis and management of autistic spectrum disorder in children

Pediatrics

Volumn 107, Issue 5, 2001, Pages 1221-1226

  Sandler, A D ^a   Brazdziunas, D ^a   Cooley, W C ^a   Gonzalez de Pijem L ^a   Hirsch, D ^a   Kastner, T A ^a   Kummer, M E ^a   Quint, R D ^a   Ruppert, E S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTISM; BEHAVIOR THERAPY; CHILD BEHAVIOR; CHILD DEVELOPMENT; EARLY DIAGNOSIS; EDUCATION; GENETIC COUNSELING; HUMAN; OCCUPATIONAL THERAPY; PARENT COUNSELING; PEDIATRICIAN; PHYSIOTHERAPY; PLAY THERAPY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SOCIAL ADAPTATION; ARTICLE; CHILD; PEDIATRICS; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE;

AUTISTIC DISORDER; CHILD; HUMANS; PEDIATRICS; PHYSICIAN'S ROLE;

EID: 0035002466     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.107.5.1221     Document Type: Review

References (70)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994
2. American Academy of Pediatrics, Committee on Children With Disabilities. Technical report: the pediatrician's role in the diagnosis and management of autistic spectrum disorder in children. Pediatrics. 2001;107: (5). URL: http://www.pediatrics.org/cgi/content/full/107/5/e85
3. Filipek PA, Accardo PJ, Baranek GT, et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord. 1999;29:439-484
4. Filipek PA, Accardo PJ, Ashwal S, et al. Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology. 2000;55:468-479
5. Wing L. The autistic spectrum. Lancet. 1997;350:1761-1766
6. Dawson G, Osterling J. Early intervention in autism. In: Guralnick MJ, ed. The Effectiveness of Early Intervention. Baltimore, MD: Paul H. Brookes Publishing Co; 1997:307-326
7. Hurth J, Shaw E, Izeman SG, Whaley K, Rogers SJ. Areas of agreement about effective practices among programs serving young children with autism spectrum disorders. Infants Young Child. 1999;12:17-26
8. Rogers SJ, Lewis H. An effective day treatment model for young children with pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry. 1989;28:207-214
9. Hoyson M, Jamisson B, Strain PS. Individualized group instruction of normally developing and autistic-like children: the LEAP curriculum model. J Div Early Child. 1984;8:157-172
10. Lovaas OI. Behavioral treatment and normal educational and intellectual functioning in young autistic children. J Consult Clin Psychol. 1987; 55:3-9
11. Harris SI, Handleman JS, Gordon R, Kristoff B, Fuentes F. Changes in cognitive and language functioning of preschool children with autism. J Autism Dev Disord. 1991;21:281-290
12. McEachin JJ, Smith T, Lovaas OI. Long-term outcome for children with autism who received early intensive behavioral treatment. Am J Ment Retard. 1993;97:359-372
13. Greenspan SI, Wieder S. Developmental patterns and outcomes in infants and children with disorder of relating and communicating: a chart review of 200 cases of children with autistic spectrum diagnoses. J Dev Learning Disord. 1997;1:87-141
14. Smith T, Eikeseth S, Klevstrand M, Lovaas O. Intensive behavioral treatment for preschoolers with severe mental retardation and pervasive developmental disorder. Am J Ment Retard. 1997;102:238-249
15. Smith T, Lovaas OI. Intensive and early behavioral intervention with autism: the UCLA young autism project. Infants Young Child. 1998;10: 67-78
16. Letter V. Epidemiology of autistic conditions in young children. 1. Prevalence. Soc Psychiatry. 1966;1:124-137
17. Gillberg C, Wing L. Autism: not an extremely rare disorder. Acta Psychiatr Scand. 1999;99:399-406
18. Fombonne E. The epidemiology of autism: a review. Psychol Med. 1999; 29:769-786
19. Centers for Disease Control and Prevention. Prevalence of Autism in Brick Township, New Jersey, 1998: Community Report. Atlanta, GA: Centers for Disease Control and Prevention; 2000. Available at: http:// www.cdc.gov/nceh/cddh/dd/report.htm. Accessed February 16, 2001
20. Honda H, Shimizu Y, Misumi K, Niimi M, Ohashi Y. Cumulative incidence and prevalence of childhood autism in children in Japan. Br J Psychiatry. 1996;169:228-235
21. Arvidsson T, Danielsson B, Forsberg P, Gillberg C, Johansson M, Kjellgren G. Autism in 3-6-year-old children in a suburb of Goeteborg, Sweden. Autism. 1997;1:163-173
22. Kadesjo B, Gillberg C, Hagberg B. Brief report: autism and Asperger syndrome in seven-year-old children: a total population study. J Autism Dev Disord. 1999;29:327-331
23. Baird G, Charman T, Baron-Cohen S, et al. A screening instrument for autism at 18 months of age: a 6-year follow-up study. J Am Acad Child Adolesc Psychiatry. 2000;39:694-702
24. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351:637-641
25. Gillberg C, Heijbel H. MMR and autism. Autism. 1998;2:423-424
26. Taylor B, Miller E, Farrington CP, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet. 1999;353:2026-2029
27. Fombonne E. Epidemiologic surveys of autism. In: Volkmar FR, ed. Autism and Pervasive Developmental Disorders. Cambridge, England: Cambridge University Press; 1999:32-63
28. DeStefano F, Chen RT. Negative association between MMR and autism. Lancet. 1999;353:1987-1988
29. Halsey NA, Hyman S, Bauman ML, et al. Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations conference. Pediatrics. 2001;107:000-000
30. Patja A, Davidkin I, Kurki T, Kallio MJT, Valle M, Peltola H. Serious adverse events after measles-mumps-rubella vaccination during a four-teen-year prospective follow-up. Pediatr Infect Dis J. 2000;19:1127-1135
31. Chess S. Follow-up report on autism in congenital rubella. J Autism Child Schizophr. 1977;7:69-81
32. Ziring PR. Congenital rubella: the teenage years. Pediatr Ann. 1997;6: 762-770
33. Bailey A, Phillips W, Rutter M. Autism: towards an integration of clinical, genetic, neuropsychological, and neurobiological perspectives. J Child Pyschol Psychiatry. 1996;37:89-126
34. Rutter M, Bailey A, Simonoff E, Pickles A. Genetic influences and autism. In: Cohen DJ, Volkmar FR, eds. Handbook of Autism and Pervasive Developmental Disorders. New York, NY: Wiley & Sons; 1997;370-387
35. Simonoff E. Genetic counseling in autism and pervasive developmental disorders. J Autism Dev Disord. 1998;28:447-456
36. New York State Department of Health, Early Intervention Program. Autism/Pervasive Developmental Disorders: Assessment and Intervention for Young Children (Age 0-3 Years). Albany, NY: New York State Department of Health; 1999. Publ. No. 4217
37. Volkmar F, Cook EH Jr, Pomeroy J, Realmuto G, Tanguay P. Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. American Academy of Child and Adolescent Psychiatry, Working Group on Quality Issues. J Am Acad Child Adolesc Psychiatry. 1999; 38(suppl):32S-54S
38. Nickel RE. Controversial therapies for young children with developmental disabilities, Infants Young Child. 1996;8:29-40
39. Hyman SL, Levy SE. Autistic spectrum disorders: when traditional medicine is not enough. Contemp Pediatr. 2000;17:101-116
40. Glascoe FP. It's not what it seems. The relationship between parents' concerns and children with global delays. Clin Pediatr (Phila). 1994;33: 292-296
41. Glascoe FP. Parents' concerns about children's development: prescreening technique or screening test? Pediatrics. 1997;99:522-528
42. Glascoe FP, Dworkin PH. The role of parents in the detection of developmental and behavioral problems. Pediatrics. 1995;95:829-836
43. Glascoe FP, MacLean WE, Stone WL. The importance of parents' concerns about their child's behavior. Clin Pediatr (Phila). 1991;30:8-11
44. Farber JM. Autism and other communication disorders. In: Capute AJ, Accardo PJ, eds. Developmental Disabilities in Infancy und Childhood, 2nd ed. Volume I: Neurodevelopmental Diagnosis and Treatment. Baltimore, MD: Paul H. Brookes Publishing Co; 1996:347
45. Capute AJ, Accardo PJ. A neurodevelopmental perspective on the continuum of developmental disabilities. In: Capute AJ, Accardo PJ. Developmental Disabilities in Infancy and Childhood, 2nd ed. Volume I: Neurodevelopmental Diagnosis and Treatment. Baltimore, MD: Paul H. Brookes Publishing Co; 1996:1-14
46. National Institute of Neurological Disease and Stroke. Human Communication and Its Disorders: An Overview'. Bethesda, MD: US Department of Health Education and Welfare; 1970
47. American Academy of Pediatrics, Task Force on Definition of the Medical Home. The medical home. Pediatrics. 1992;90:774
48. American Academy of Pediatrics. The medical home statement addendum: pediatric primary health care. AAP News. November. 1993;7
49. American Academy of Pediatrics, Committee on Children With Disabilities. Developmental surveillance and screening in young children. Pediatrics. 2001. In press
50. American Academy of Pediatrics. The Classification of Child and Adolescent Mental Diagnoses in Primary Care: Diagnostic and Statistical Manual for Primary Care (DSM-PC), Child and Adolescent Version. Wolraich ML, ed. Elk Grove Village, IL: American Academy of Pediatrics; 1996
51. Baron-Cohen S, Allen J, Gillberg C. Can autism be detected at 18 months? The needle, the haystack, and the CHAT. Br J Psychiatry. 1992;161:839-843
52. Baron-Cohen S, Cox A, Baird G, et al. Psychological markers in the detection of autism in infancy in a large population. Br J Psychiatry. 1996;168:158-163
53. Cox A, Klein K, Charman T, et al. Autism spectrum disorders at 20 and 42 months of age: stability of clinical and ADI-R diagnosis. J Child Psychol Psychiatry. 1999;40:719-732
54. Siegel B. Early screening and diagnosis in autism spectrum disorders: the pervasive developmental disorders screening test (PDDST). Paper presented at: The State of the Science in Autism: Screening and Diagnosis Working Conference; June 15-17, 1998; Bethesda, MD
55. Bailey A, Luthert P, Bolton P, Le Couteur A, Rutter M, Harding B. Autism and megalencephaly. Lancet. 1993;341:1225-1226
56. Lainhart JE, Piven J, Wzorek M, et al. Macrocephaly in children and adults with autism. J Am Acad Child Adolesc Psychiatry. 1997;36:282-290
57. Gillberg C, Coleman M. Autism and medical disorders: a review of the literature. Dev Med Child Neurol. 1996;38:191-202
58. Filipek PA. Neuroimaging in the developmental disorders: the state of the science. J Child Psychol Psychiatry. 1999;40:113-128
59. Filipek PA. Brief report: neuroimaging in autism: the state of the science 1995. I Autism Dev Disant. 1996;26:211-215
60. Bregman JD, Gerdtz J. Behavioral interventions. In: Cohen DJ, Volkmar FR, eds. Handbook of Autism and Pervasive Developmental Disorders. 2nd ed. New York, NY: Wiley & Sons; 1997:606-630
61. Powers MD. Behavioral assessment of individuals with autism. In: Cohen DJ, Volkmar FR, eds. Handbook of Autism and Pervasive Developmental Disorders. 2nd ed. New York, NY: Wiley & Sons; 1997:448-459
62. Wetherby A, Prizant B. Facilitating language and communication development in autism: assessment and intervention guidelines. In: Zager DB, ed. Autism: Identification, Education, and Treatment. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum; 1999
63. Tsai LY. Brief report: comorbid psychiatric disorders of autistic disorder. J Autism Dev Disord. 1996;26:159-163
64. Rapin I. Autism. N Engl J Med. 1997;337:97-104
65. McDougle CJ. Psychopharmacology. In: Cohen DJ, Volkmar FR, eds. Handbook of Autism and Pervasive Developmental Disorders. 2nd ed. New York, NY: Wiley & Sons; 1997:707-729
66. DeLong GR, Teague LA, McSwain Kamran M. Effects of fluoxetine treatment in young children with idiopathic autism. Dev Med Child Neurol. 1998;40:551-562
67. Khan BU. Brief report: risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults. J Autism Dev Disord. 1997;27:479-489
68. Steingard RJ, Zimnitzky B, DeMaso DR, Bauman ML, Bucci JP. Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder. J Child Adolesc Psychopharmacol. 1997;7:9-15
69. Individuals With Disabilities Education Act. Pub L No. 94-142 (1990)
70. Individuals With Disabilities Education Act. Pub L No. 105-17 (1997)